1/5/2012 7:40:20 AM
AUSTIN, Texas--(BUSINESS WIRE)--Mirna Therapeutics, Inc. (Mirna), a biotechnology company pioneering microRNA replacement therapy for cancer, announced that it is scheduled to present on Monday, January 9th, 2012 at 3:00 pm at Biotech Showcase 2012 in San Francisco. Dr. Paul Lammers, Mirna’s President and Chief Executive Officer, will present a corporate overview, summarizing the key events and accomplishments in 2011 and the 2012 focus, including:
•The completion of an extensive evaluation of external delivery technologies.
comments powered by